Short Wave Pharma
Psilocybin-based Products for Treatment of Mental Health Disorders
Company Overview
Snapshot
Founded in January 2021 by Rivki Stern Youdkevich, Stephen Murphy, and Nadya Lisovoder, Short Wave Pharma operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing novel psilocybin-based therapies. In August 2022, Short Wave Pharma announced a partnership for a clinical trial focused on eating disorders.
Business overview
Short Wave Pharma is a biopharmaceutical company specializing in the development of novel formulations of psilocybin and other active pharmaceutical ingredients (APIs). The company focuses on creating customized delivery methods to treat mental health disorders, neurodegenerative diseases, and chronic pain. Operating within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology, Short Wave Pharma serves the healthcare and life sciences industries with a focus on pharmaceutical solutions.
Strategic signal
In August 2022, Short Wave Pharma announced a partnership for a clinical trial targeting eating disorders with the Sheba Fund. This collaboration signals the company's progression into clinical development and validation of its psilocybin-based therapies, indicating a strategic move towards addressing significant unmet medical needs in mental health.
Log in to access full profile ›Company Intelligence Q&A
- What is Short Wave Pharma's primary focus?
- Short Wave Pharma is a biopharmaceutical company developing novel formulations of psilocybin and additional APIs, along with customized delivery methods, for patients living with mental health disorders, neurodegenerative diseases, and chronic pain.
- When was Short Wave Pharma founded and by whom?
- Short Wave Pharma was founded in January 2021 by Rivki Stern Youdkevich, Stephen Murphy, and Nadya Lisovoder.
- What is the current employee size of Short Wave Pharma?
- Short Wave Pharma currently has 1–10 employees.
- What is a significant recent development for Short Wave Pharma?
- In August 2022, Short Wave Pharma partnered in a clinical trial for eating disorders with the Sheba Fund, as reported by CTech.
- What is Short Wave Pharma's product development stage?
- Short Wave Pharma is currently in the clinical trial stage, with preclinical studies underway for its product targeting anorexia nervosa.